Nooshin Khobzi Rotondi
PhD

Research and Expertise

• Background and Interests

  Nooshin Rotondi received her PhD in Epidemiology in 2011 from the University of Western Ontario in London, Ontario.

  Research Interests and Areas of Specialty:  

  • Health of marginalized communities and issues of health equity
  • Health service access
  • Substance use and mental health
  • Community-based research
  • Research methods and statistics, including sampling of hard-to-reach populations, analysis of large population-based datasets, and modelling of complex survey data

  Dr. Rotondi is particularly interested in the identifying and mitigating health care inequities experienced by vulnerable populations.

• Education
  • PhD, Epidemiology, University of Western Ontario, 2011
  • BSc (Honours), University of Toronto, 2006
• Courses taught
  • HLSC 2700U – Mathematical Reasoning in Health Sciences
  • HLSC 3800U – Introduction to Statistics in Health Sciences
  • HLSC 3805U – Introduction to Epidemiology
• Publications

  For a comprehensive list of publications, visit  Google Scholar. 

  • Rotondi NK, Beaton DE, Sujic R, Sale JEM, Ansari H, Elliot-Gibson V, et al. Identifying and addressing barriers to osteoporosis treatment was associated with improved outcomes: An observational cohort study. The Journal of Rheumatology. 2018;45(11):1549-1601.
  • Urbanoski K, Kenaszchuk C, Inglis D, Rotondi NK, Rush B. A system-level study of initiation, engagement, and equity in outpatient substance use treatment. Journal of Substance Abuse Treatment. 2018;90:19-28.
  • Abtan R, Rotondi NK, Macpherson A, Rotondi MA. The effect of informal caregiver support on utilization of acute health services among home care clients: A prospective observational study. BMC Health Services Research. 2018;18(73).
  • Ansari H, Beaton D, Sujic R, Rotondi NK, Cullen JD, Slater M, et al. Equal treatment: no evidence of gender inequity in osteoporosis management in a coordinator-based fragility fracture screening program. Osteoporosis International. 2017;28(12):3401-3406.
  • Beaton DE, Vidmar M, Pitzul KB, Sujic R, Rotondi NK, Bogoch ER, et al. Addition of a fracture risk assessment to a coordinator’s role improved treatment rates within 6 months of screening in a fragility fracture screening program. Osteoporosis International. 2017;28(3):863- 869.
  • Rotondi NK, Beaton DE, Ilieff M*, Adhihetty C, Linton D, Bogoch ER, et al. The impact of fragility fractures on work and characteristics associated with time to return to work. Osteoporosis International. 2016;28(1):349-358.
  • Rotondi NK, Beaton DE, Elliot-Gibson V, Sujic R, Josse RG, Sale JEM, et al. Comparison of CAROC and FRAX in fragility fracture patients: Agreement, clinical utility and implications for clinical practice. The Journal of Rheumatology. 2016;43(8):1593-1599.
  • Rush B, Chau N, Rotondi NK, Tan F, Detfurth E. Recovery monitoring for substance use treatment in Ontario: Outcome results from a feasibility assessment. Canadian Journal of Addiction. 2016;7(3):5-14.
  • Strike C, Rotondi NK, Watson TM, Kolla G, Bayoumi AM. Public opinions about supervised smoking facilities for crack cocaine and other stimulants. Substance Abuse Treatment, Prevention, and Policy. 2016;11(8), doi: 10.1186/s13011-016-0052-7.
  • Hart TA, Rotondi NK, Souleymanov R, Brennan DJ. Psychometric properties of the Social Appearance Anxiety Scale among Canadian gay and bisexual men of color. Psychology of Sexual Orientation and Gender Diversity. 2015;2(4):470-481.
• Research Collaborators
  • St. Michael’s Hospital
• Grants
  • Beaton DE (PI), Jain R, Bogoch E, Da Costa D, Fortin P, Gignac M, Jaglal S, Josse R, Kennedy C, Mamdani M, Rotondi NK, Sale J, Sujic R, Thorpe K. “Make this break your last”: Pilot testing an educational intervention to improve fragility fracture patients’ awareness of their risk of refracture. $210,196 funded by CIHR. Apr-01-2015 – Mar-31- 2017.
  • Urbanoski K (PI), Rush BR, Rotondi NK, Callaghan RC. Quality care for all: A system-level evaluation of performance and equity in addiction treatment. $149,110 funded by CIHR (MOP 126057). Apr-01-2013 – Mar-31-2015.
  • Bauer GR (PI), Travers R (PI), Rotondi NK, Hammond R, Hancock-Boyce M, Pyne J, Thind A. Social exclusion, erasure and the health of transgender people: Trans PULSE. $167,014 funded by CIHR (MOP 167492). Apr-01-2010 – Mar-31-2013.